Editorial & Columns Different Routes and Same Destination: Indian Pharmaceutical & FMCG Companies in Wellness Segment August 14, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns In Perfect Balance-Inflation and Development August 14, 2024 | Satish Singh | No Comments | More
Editorial & Columns Delhi remains vulnerable to Centre’s wishes August 10, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Army’s Renewed Role :Muhammad Yunus Becomes the Face of the Hybrid Regime in Dacca August 6, 2024 | Gopal Misra | No Comments | More
Editorial & Columns Risk Management and Pharmaceutical Companies in India August 6, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns No need to be panic, Indian Stock Market remain strong & resilient August 6, 2024 | Satish Singh | No Comments | More
Editorial & Columns Reformed NITI Aayog to boost federalism August 3, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Killing of the Hamas Leader : Spins off the Race for Multi-billion USD Business for Laser Weapons August 1, 2024 | Gopal Misra | No Comments | More
Editorial & Columns Voluntary Licensing in Pharmaceutical Industry: Impact on Market Access & Pricing August 1, 2024 | Dr. Anil Kumar Angrish | No Comments | More